Genedrive PLC (AIM: GDR), the developer of rapid genetic testing technology, expects total income for the year ended 30 June to rise to around £1 million, up from £0.5 million
Share Talk Weekly Stock Market News Review, Sunday 1st june 2025
London stocks close the week on a high note. The blue-chip FTSE 100 rose 0.6%, while the mid-cap FTSE 250 edged up 0.1%. Despite the renewed geopolitical tension, the FTSE
Genedrive PLC (AIM:GDR) received European regulatory approval
Genedrive wins EU approval for rapid genetic test aimed at stroke and heart attack care
Share Talk Weekly Stock Market News Review, Sunday 16th March 2025
Investors shrugged off pessimism at the close of play on Friday. The FTSE 100 climbed by 1.1%, while the UK-centric FTSE 250 advanced by 1.6%. Gold reached a record high
Genedrive PLC (AIM:GDR) CYP2C19-ID Kit adopted for routine clinical use
North West Anglia Foundation NHS Trusts’ Peterborough City Hospital implements the Genedrive® CYP2C19-ID Kit for routine clinical use
RNS Hotlist with Zak Mir: SCGL, THR, HE1, ALL, RMR, EEE, ROQ & GDR
Sealand Capital Galaxy (SCGL), an IT, Social Media & Technology company focused on consolidating compelling technology opportunities in the global marketplace, is pleased to announce that the Company’s strategic investee &
RNS Hotlist with Zak Mir: CNA, ZEN, RMR, GDR, SRT & VSA
In its Trading Update on 10 December 2024, Centrica (CNA) announced a £300 million extension of the Company’s share repurchase programme to be completed by the end of September 2025.
Genedrive PLC (AIM:GDR) Genedrive® CYP2C19-ID Kit performance published
Superior performance to laboratory test and alternative available point of care platforms
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 13th December 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, ALL ,
RNS Hotlist with Zak Mir: SVML, SNDA, HEX, CEL, EST, PANR, GWMO, GDR, MET1 & TIG
Sovereign Metals (SVML) announced it has commenced an infill drilling program at its Kasiya Rutile-Graphite Project (Kasiya or Project) in Malawi to support ongoing technical studies.
Genedrive (AIM:GDR) shares fall 10% following CEO departure
Genedrive PLC (AIM: GDR) shares dropped 10% after the announcement that CEO James Cheek has left the company by mutual agreement.
Genedrive PLC (AIM: GDR) NICE recommends CYP2C19-ID Kit in final guidance
NICE recommends the Genedrive® CYP2C19-ID Kit in final guidance Genedrive® CYP2C19-ID test chosen as the preferred platform for point-of-care genotype testing prior to clopidogrel treatment for stroke patients in the